LeonaBio
LONA

LeonaBio (LONA) analyst forecast and price target

Analyst forecast

Buy

Consensus of 4 analyst ratings

Buy
4
Hold
0
Sell
0

Recent analyst ratings

FirmActionRatingPrice targetDate
MizuhoMaintainedOutperform$15.00 from $16.00Aug 19, 2026
CitizensMaintainedMarket Outperform$17.00 from $18.00Aug 17, 2026
CitizensUpgradedMarket Perform → Market Outperform$18.00Jul 30, 2026
Piper SandlerInitiated CoverageOverweight$20.00May 27, 2026
MizuhoUpgradedNeutral → Outperform$10.00Feb 19, 2026
MizuhoDowngradedOutperform → Neutral$0.50 from $5.00Sep 19, 2024
BTIGDowngradedBuy → NeutralSep 4, 2024
JMP SecuritiesDowngradedMarket Outperform → Market PerformSep 4, 2024
Rodman & RenshawInitiated CoverageBuy$22.00Aug 19, 2024
JMP SecuritiesMaintainedMarket Outperform$19.00Jun 20, 2024
JMP SecuritiesMaintainedMarket Outperform$19.00May 16, 2024
JMP SecuritiesMaintainedOutperform$19.00 from $20.00Aug 11, 2023
MizuhoMaintainedBuy$5.00 from $6.00May 15, 2023
BTIGMaintainedBuy$10.00 from $33.00Mar 30, 2023
JMP SecuritiesMaintainedMarket Outperform$20.00Mar 24, 2023

Frequently asked questions

  • Is LONA a buy, sell, or hold?

    Analysts covering LeonaBio currently average a Buy rating: 4 buy, 0 hold and 0 sell, from 4 analysts. Ratings reflect analyst opinion, not investment advice.

  • What is the latest analyst rating on LONA?

    On Aug 19, 2026, Mizuho maintained LeonaBio at Outperform with a price target of $15.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.